Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Allahyari A, Ehsanpour A, Najafi B, Ansarinejad N, Mehrzad V, Kalantari B, Raafat J, Ghadiany M, Shahi F, Gharib B, Moazed V, Khosravi A, Mirpour MH, Salari S, Mortazavizadeh S, Nekoyi A, Khani M, Sadeghi A, Gharib S, Bary A, Mirzania M, Haghighat S, Razavi SM, Emami SAH, Hosseinzadeh M, Mirbolouk M, Sadighi S, Shahrasbi A, Esfahani A, Gity M, Anjidani N, Kafi H, Najafi S. Allahyari A, et al. Among authors: moazed v. BMC Cancer. 2022 Sep 7;22(1):960. doi: 10.1186/s12885-022-09895-5. BMC Cancer. 2022. PMID: 36071409 Free PMC article. Clinical Trial.
A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients.
Nodehi RS, Kalantari B, Raafat J, Ansarinejad N, Moazed V, Mortazavizadeh SMR, Hosseinzadeh M, Ghaderi B, Jenabian A, Qadyani M, Haghighat S, Allahyari A, Mirzania M, Seghatoleslami M, Payandeh M, Alikhasi A, Kafi H, Shahi F. Nodehi RS, et al. Among authors: moazed v. BMC Pharmacol Toxicol. 2022 Jul 28;23(1):57. doi: 10.1186/s40360-022-00599-x. BMC Pharmacol Toxicol. 2022. PMID: 35902898 Free PMC article. Clinical Trial.
Serum levels of Organochlorine Pesticides and Breast Cancer Risk in Iranian Women.
Paydar P, Asadikaram G, Fallah H, Zeynali Nejad H, Akbari H, Abolhassani M, Moazed V, Khazaeli P, Heidari MR. Paydar P, et al. Among authors: moazed v. Arch Environ Contam Toxicol. 2019 Nov;77(4):480-489. doi: 10.1007/s00244-019-00648-3. Epub 2019 Jul 19. Arch Environ Contam Toxicol. 2019. PMID: 31324944
Fatal Case of Plasmodium vivax Malaria in a Splenectomized Patient.
Mahmoudvand H, Farivar L, Sharifi I, Harandi MF, Moazed V, Jahanbakhsh S, Babaei Z, Zia-Ali N. Mahmoudvand H, et al. Among authors: moazed v. Iran J Parasitol. 2012;7(3):99-102. Iran J Parasitol. 2012. PMID: 23109969 Free PMC article.
Opium Use and Head and Neck Cancers: A Matched Case-Control Study in Iran.
Alizadeh H, Naghibzadeh Tahami A, Khanjani N, Yazdi-Feyzabadi V, Eslami H, Borhaninejad V, Larizadeh MH, Enhesari A, Abbasi-Rayeni R, Moazed V, Arabi Mianroodi A. Alizadeh H, et al. Among authors: moazed v. Asian Pac J Cancer Prev. 2020 Mar 1;21(3):783-790. doi: 10.31557/APJCP.2020.21.3.783. Asian Pac J Cancer Prev. 2020. PMID: 32212808 Free PMC article.
22 results